Literature DB >> 19647220

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

David G DeNardo1, Jairo B Barreto, Pauline Andreu, Lesley Vasquez, David Tawfik, Nikita Kolhatkar, Lisa M Coussens.   

Abstract

During breast cancer development, increased presence of leukocytes in neoplastic stroma parallels disease progression; however, the functional significance of leukocytes in regulating protumor versus antitumor immunity in the breast remains poorly understood. Utilizing the MMTV-PyMT model of mammary carcinogenesis, we demonstrate that IL-4-expressing CD4(+) T lymphocytes indirectly promote invasion and subsequent metastasis of mammary adenocarcinomas by directly regulating the phenotype and effector function of tumor-associated CD11b(+)Gr1(-)F4/80(+) macrophages that in turn enhance metastasis through activation of epidermal growth factor receptor signaling in malignant mammary epithelial cells. Together, these data indicate that antitumor acquired immune programs can be usurped in protumor microenvironments and instead promote malignancy by engaging cellular components of the innate immune system functionally involved in regulating epithelial cell behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647220      PMCID: PMC2778576          DOI: 10.1016/j.ccr.2009.06.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  40 in total

Review 1.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.

Authors:  Edward Y Woo; Heidi Yeh; Christina S Chu; Katia Schlienger; Richard G Carroll; James L Riley; Larry R Kaiser; Carl H June
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

4.  Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma.

Authors:  Michael Girardi; David Oppenheim; Earl J Glusac; Renata Filler; Allan Balmain; Robert E Tigelaar; Adrian C Hayday
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

5.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

Authors:  Enrico Giraudo; Masahiro Inoue; Douglas Hanahan
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors.

Authors:  Jeffrey Wyckoff; Weigang Wang; Elaine Y Lin; Yarong Wang; Fiona Pixley; E Richard Stanley; Thomas Graf; Jeffrey W Pollard; Jeffrey Segall; John Condeelis
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 7.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.

Authors:  Bernard Uzzan; Patrick Nicolas; Michel Cucherat; Gérard-Yves Perret
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 8.  Naturally occurring B-cell responses to breast cancer.

Authors:  Julia A Coronella-Wood; Evan M Hersh
Journal:  Cancer Immunol Immunother       Date:  2003-08-15       Impact factor: 6.968

9.  Immune enhancement of skin carcinogenesis by CD4+ T cells.

Authors:  Dylan Daniel; Nicole Meyer-Morse; Emily K Bergsland; Kerstin Dehne; Lisa M Coussens; Douglas Hanahan
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

10.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  551 in total

1.  Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Authors:  Josie Ursini-Siegel; Sean Cory; Dongmei Zuo; William R Hardy; Elton Rexhepaj; Sonya Lam; Babette Schade; Karin Jirstrom; Eva Bjur; Ciriaco A Piccirillo; David Denardo; Lisa M Coussens; Donal J Brennan; William M Gallagher; Morag Park; Tony Pawson; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

Review 2.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

3.  Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

Authors:  Gabriela Schiechl; Bernhard Bauer; Ivan Fuss; Sven A Lang; Christian Moser; Petra Ruemmele; Stefan Rose-John; Markus F Neurath; Edward K Geissler; Hans-Jürgen Schlitt; Warren Strober; Stefan Fichtner-Feigl
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

4.  TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.

Authors:  Sergey V Novitskiy; Michael W Pickup; Agnieszka E Gorska; Philip Owens; Anna Chytil; Mary Aakre; Huiyun Wu; Yu Shyr; Harold L Moses
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 5.  Transcriptional regulation of macrophage polarization: enabling diversity with identity.

Authors:  Toby Lawrence; Gioacchino Natoli
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

6.  Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors:  Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

Review 7.  Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.

Authors:  Katherine Venmar Bankaitis; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2015-09-18       Impact factor: 5.150

8.  Identification of candidate genes that may contribute to the metastasis of prostate cancer by bioinformatics analysis.

Authors:  Lingyun Liu; Kaimin Guo; Zuowen Liang; Fubiao Li; Hongliang Wang
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

Review 9.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 10.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.